ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,833.60
      -0.06%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      85.54
      -1.12%
      Bitcoin
      57,653.14
      3.23%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Serono S A (SRA)

      7. Serono S A (SRA) News

      SRA

      Serono (SRA)

      Serono S A
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:SRA
      DateTimeSourceHeadlineSymbolCompany
      04/20/20062:02AMPR Newswire (US)Serono Delivers Strong First Quarter 2006 With Revenue Growth of 16.4% in Local CurrenciesNYSE:SRA
      04/10/20062:02AMPR Newswire (US)Serono Announces Termination of Discussions Concerning a Sale of the CompanyNYSE:SRA
      04/04/20062:02AMPR Newswire (US)Serono Submits New Formulation of Rebif(R) for Approval in the United States and in EuropeNYSE:SRA
      03/31/20061:02AMPR Newswire (US)Serono's Board of Directors to Propose an Increase in Authorized Share Capital to the Forthcoming Annual Shareholders' MeetingNYSE:SRA
      03/15/20064:04PMPR Newswire (US)BioMarin and Serono Announce Positive Results From Phase 3 Clinical Study of Phenoptin for PKUNYSE:SRA
      03/15/20064:00PMPR Newswire (US)BioMarin and Serono Announce Positive Results From Phase 3 Clinical Study of Phenoptin for PKUNYSE:SRA
      02/06/20061:02AMPR Newswire (US)Seronons 2005 Adjusted(i) EPS Increased by 34.6%NYSE:SRA
      01/24/20061:01AMPR Newswire (US)Serono's Gonal-f(R) Approved in Japan for the Treatment of Male Hypogonadotropic HypogonadismNYSE:SRA
      01/09/20061:01AMPR Newswire (US)Serono Completes Second Phase III Trial of its Proprietary Recombinant Human Growth Hormone for HIV-Associated Adipose RedistribNYSE:SRA
      12/15/20051:19PMPR Newswire (US)Serono Announces Formal Conclusion of Serostim SettlementNYSE:SRA
      11/16/20052:00AMPR Newswire (US)Eurand Appoints Chief Scientific OfficerNYSE:SRA
      11/09/20052:01AMPR Newswire (US)Immune Response to Influenza Vaccine is Maintained in MS Patients Treated With Rebif(R)NYSE:SRA
      11/08/20057:09AMPR Newswire (US)Goldman Sachs Retained to Explore Strategic AlternativesNYSE:SRA
      11/03/20058:01AMPR Newswire (US)Brooke Shields Lends Her Support to Encourage Women to Take Action Early if They Have Trouble ConceivingNYSE:SRA
      10/25/20058:30AMPR Newswire (US)Serono and Rigel Sign Agreement to Develop and Commercialize Aurora Kinase InhibitorsNYSE:SRA
      10/25/20052:01AMPR Newswire (US)Serono and Rigel Sign Agreement to Develop and Commercialize Aurora Kinase InhibitorsNYSE:SRA
      10/25/20052:00AMPR Newswire (US)Serono's Third Quarter 2005 Adjusted EPS Increased by 37.6%NYSE:SRA
      10/17/200512:40PMPR Newswire (US)Serono Announces Final Settlement of Serostim(R) InvestigationNYSE:SRA
      10/17/20059:02AMPR Newswire (US)Serono Announces Significant Advances in Identifying Most Viable Embryos for Transfer During IVF ProceduresNYSE:SRA
      10/03/20056:30PMPR Newswire (US)Serono: Data And Safety Monitoring Board Recommends Discontinuation of Canvaxin(TM) Phase 3 Clinical Trial for Patients With StaNYSE:SRA
      08/18/20052:00AMPR Newswire (US)Serono and Genmab Announce Global Development and Commercialization Agreement for Humax-CD4NYSE:SRA
      07/19/20055:01PMPR Newswire (US)Serono Delivers Strong Second Quarter ResultsNYSE:SRA
      07/13/20053:54AMPR Newswire (US)Serono Welcomes Positive Ratings From Credit AgenciesNYSE:SRA
      06/14/20055:08PMPR Newswire (US)Serono and Priority Healthcare Corporation Form Strategic AllianceNYSE:SRASerono S A
      05/17/20052:00AMPR Newswire (US)Serono and NovImmune to Collaborate in Development of Two Novel Treatments for Autoimmune DiseasesNYSE:SRA
      05/16/20051:30AMPR Newswire (US)BioMarin And Serono Form Strategic ALLIANCE for the Development and Commercialization of Phenoptin(TM) and Phenylase(TM)NYSE:SRA
      05/16/20051:30AMPR Newswire (US)BioMarin and Serono Form Strategic Alliance for the Development and Commercialization of Phenoptin(TM) and Phenylase(TM)NYSE:SRA
      05/02/20053:12AMPR Newswire (US)Serono and Genmab Sign Worldwide Agreement to Develop and Commercialize HuMax-TACNYSE:SRA
      05/02/20052:00AMPR Newswire (US)Serono and Genmab Sign Worldwide Agreement to Develop and Commercialize HuMax-TACNYSE:SRA
      04/26/200512:00PMPR Newswire (US)Serono Shareholders Approve Resolutions at Annual General MeetingNYSE:SRA
       Showing the most relevant articles for your search:NYSE:SRA